Recent advances in early diagnosis and treatment of T1D with miRNAs
Type 1 diabetes (T1D) is an autoimmune disease characterized by T cell-mediated destruction of pancreatic β-cells and is one of the most common chronic diseases in adults and children. In recent years, the incidence of T1D has been increasing worldwide. Currently, the diagnosis of T1D relies on clin...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1582963/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850135434830544896 |
|---|---|
| author | Xinling Zhang Yuting Qiu Dong-ang Liu Ruiyao Hu Shiyu Chen Yue Xu Keyi Chen Jinghua Yuan Xiaoping Li |
| author_facet | Xinling Zhang Yuting Qiu Dong-ang Liu Ruiyao Hu Shiyu Chen Yue Xu Keyi Chen Jinghua Yuan Xiaoping Li |
| author_sort | Xinling Zhang |
| collection | DOAJ |
| description | Type 1 diabetes (T1D) is an autoimmune disease characterized by T cell-mediated destruction of pancreatic β-cells and is one of the most common chronic diseases in adults and children. In recent years, the incidence of T1D has been increasing worldwide. Currently, the diagnosis of T1D relies on clinical manifestations and autoantibody detection, with a lack of early predictive biomarkers. MicroRNAs (miRNAs), as crucial post-transcriptional regulatory factors, which are involved in various biological processes, including cell division, proliferation, differentiation, development, and metabolism. Additionally, miRNAs participate in the regulation of inflammatory complications in T1D, and their aberrant expression is closely associated with the disease. The stability of miRNAs makes them potential candidates for early diagnostic biomarkers and therapeutic targets in T1D. This paper discusses the pathogenesis of T1D and the potential applications of miRNAs in early diagnosis and interventional therapy. It provides references for advancing precision diagnosis and personalized treatment strategies through more profound miRNA research in the future. |
| format | Article |
| id | doaj-art-23eafbcaf222424a9d7ff4271b1c208d |
| institution | OA Journals |
| issn | 1664-2392 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Endocrinology |
| spelling | doaj-art-23eafbcaf222424a9d7ff4271b1c208d2025-08-20T02:31:26ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922025-05-011610.3389/fendo.2025.15829631582963Recent advances in early diagnosis and treatment of T1D with miRNAsXinling ZhangYuting QiuDong-ang LiuRuiyao HuShiyu ChenYue XuKeyi ChenJinghua YuanXiaoping LiType 1 diabetes (T1D) is an autoimmune disease characterized by T cell-mediated destruction of pancreatic β-cells and is one of the most common chronic diseases in adults and children. In recent years, the incidence of T1D has been increasing worldwide. Currently, the diagnosis of T1D relies on clinical manifestations and autoantibody detection, with a lack of early predictive biomarkers. MicroRNAs (miRNAs), as crucial post-transcriptional regulatory factors, which are involved in various biological processes, including cell division, proliferation, differentiation, development, and metabolism. Additionally, miRNAs participate in the regulation of inflammatory complications in T1D, and their aberrant expression is closely associated with the disease. The stability of miRNAs makes them potential candidates for early diagnostic biomarkers and therapeutic targets in T1D. This paper discusses the pathogenesis of T1D and the potential applications of miRNAs in early diagnosis and interventional therapy. It provides references for advancing precision diagnosis and personalized treatment strategies through more profound miRNA research in the future.https://www.frontiersin.org/articles/10.3389/fendo.2025.1582963/fullT1DmiRNAsbiomarkersdiagnosiscomplicationstreatment |
| spellingShingle | Xinling Zhang Yuting Qiu Dong-ang Liu Ruiyao Hu Shiyu Chen Yue Xu Keyi Chen Jinghua Yuan Xiaoping Li Recent advances in early diagnosis and treatment of T1D with miRNAs Frontiers in Endocrinology T1D miRNAs biomarkers diagnosis complications treatment |
| title | Recent advances in early diagnosis and treatment of T1D with miRNAs |
| title_full | Recent advances in early diagnosis and treatment of T1D with miRNAs |
| title_fullStr | Recent advances in early diagnosis and treatment of T1D with miRNAs |
| title_full_unstemmed | Recent advances in early diagnosis and treatment of T1D with miRNAs |
| title_short | Recent advances in early diagnosis and treatment of T1D with miRNAs |
| title_sort | recent advances in early diagnosis and treatment of t1d with mirnas |
| topic | T1D miRNAs biomarkers diagnosis complications treatment |
| url | https://www.frontiersin.org/articles/10.3389/fendo.2025.1582963/full |
| work_keys_str_mv | AT xinlingzhang recentadvancesinearlydiagnosisandtreatmentoft1dwithmirnas AT yutingqiu recentadvancesinearlydiagnosisandtreatmentoft1dwithmirnas AT dongangliu recentadvancesinearlydiagnosisandtreatmentoft1dwithmirnas AT ruiyaohu recentadvancesinearlydiagnosisandtreatmentoft1dwithmirnas AT shiyuchen recentadvancesinearlydiagnosisandtreatmentoft1dwithmirnas AT yuexu recentadvancesinearlydiagnosisandtreatmentoft1dwithmirnas AT keyichen recentadvancesinearlydiagnosisandtreatmentoft1dwithmirnas AT jinghuayuan recentadvancesinearlydiagnosisandtreatmentoft1dwithmirnas AT xiaopingli recentadvancesinearlydiagnosisandtreatmentoft1dwithmirnas |